Clinical trial

Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication

NCT01268553

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-08-01

PhasePHASE4

Study timeline

Study start (unknown)2010-08-01Date precision: month

Registry last updated2017-09-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Arterial Hypertensionunresolved

Interventions

TreprostinilDRUG · verified · RxNorm: treprostinil

Sponsors & collaborators

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Centerlead sponsor

United Therapeuticscollaborator

Mapped research locations

San FranciscoCalifornia, United States1 TucsonArizona, United States1 TorranceCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01268553 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.